Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 9: Training Achieves Smaller Placebo Responses By Scott Millard October 10, 2017 Patient and Stakeholder Engagement 3 of the Hardest Obstacles We Face in Alzheimer’s Clinical Drug Trials By Sebastian Turek October 9, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 8: Finding Another Way By Scott Millard October 3, 2017 Patient and Stakeholder Engagement Why the time’s right for a Rare Disease Film Festival By Premier Research September 26, 2017 Clinical ResearchPhase 1 - Phase 4 The ABC’s of OA By Scott Millard September 26, 2017 Clinical ResearchPhase 1 - Phase 4 Fragile X: The Quest to Treat a Complex, Little-Understood Condition By Premier Research September 25, 2017 Previous 1 …32 33 34 35 36 … 50 Next ×
